COVID-19

Workflow Management System Market Size Worth $60.02 Billion, Globally, by 2031 – Exclusive Report by The Insight Partners

The workflow management system market size is projected to reach US$ 60.02 billion by 2031 from US$ 10.23 billion in…

1 year ago

Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis

News Summary: Waters new LC-MS grade reagents, enzymes, and software simplify large molecule RNA analysis to accelerate and improve development of mRNA…

1 year ago

Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)

– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical…

1 year ago

Global Health Exhibition to Unveil the World’s Largest Virtual Hospital in Riyadh

Exclusive exhibit will enable attendees to experience simulated patient scenarios and determine treatment and therapy actionsTechnology behind the virtual hospital…

1 year ago

Entourage Health Provides Company Update

TORONTO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a…

1 year ago

Strong validation of Evaxion’s AI-Immunology™ platform in multiple clinical trials

Data from three separate clinical trials documents the strong ability of the AI-Immunology™ platform to select clinically relevant vaccine targets…

1 year ago

Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design

The Company recently announced the positive topline results from the Phase 2b study with istaroxime in acute heart failure patients…

1 year ago

FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer

RAMAT GAN, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company…

1 year ago

Adagene Announces Upcoming Poster Presentations on Masked Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) at Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

SAN DIEGO and SUZHOU, China, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the…

1 year ago